2.54
                                            Schlusskurs vom Vortag:
              $2.55
            Offen:
              $2.52
            24-Stunden-Volumen:
                152.01K
            Relative Volume:
              0.40
            Marktkapitalisierung:
                $130.31M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              -
            KGV:
              -
            EPS:
                -
            Netto-Cashflow:
                -
            1W Leistung:
              +10.43%
            1M Leistung:
              -2.31%
            6M Leistung:
                -35.20%
            1J Leistung:
              -58.29%
            Tuhura Biosciences Inc Stock (HURA) Company Profile
Firmenname
                  
                      Tuhura Biosciences Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      813-875-6600
                    
                Adresse
                  
                      10500 UNIVERSITY CENTER DR., TAMPA
                    
                Vergleichen Sie HURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                HURA
                            
                             
                        Tuhura Biosciences Inc 
                           | 
                    2.54 | 130.31M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-03-03 | Eingeleitet | H.C. Wainwright | Buy | 
| 2024-12-19 | Eingeleitet | Rodman & Renshaw | Buy | 
| 2024-11-05 | Eingeleitet | Maxim Group | Buy | 
Tuhura Biosciences Inc Aktie (HURA) Neueste Nachrichten
How interest rate cuts could boost TuHURA Biosciences Inc. stock2025 Bull vs Bear & Smart Allocation Stock Reports - newser.com
TuHURA Biosciences Plans Phase 2 Trial for TBS-2025 - TipRanks
TuHURA Biosciences cancer research accepted for ASH presentation By Investing.com - Investing.com South Africa
TuHURA Biosciences cancer research accepted for ASH presentation - Investing.com
TuHURA’s research on delta opioid receptor in cancer therapy to be presented at ASH meeting - Investing.com South Africa
What the charts say about TuHURA Biosciences Inc. todayTrade Volume Report & Real-Time Chart Breakout Alerts - newser.com
How to build a custom watchlist for TuHURA Biosciences Inc.Earnings Summary Report & Intraday High Probability Setup Alerts - newser.com
TuHURA (NASDAQ: HURA) to present DOR-MDSC oral data at 67th ASH; TAM results included - Stock Titan
Will TuHURA Biosciences Inc. (PL3) stock draw ESG focused fundsJuly 2025 Intraday Action & Low Drawdown Investment Strategies - newser.com
How to integrate TuHURA Biosciences Inc. into portfolio analysis tools2025 Volatility Report & Verified Entry Point Detection - newser.com
Can machine learning forecast TuHURA Biosciences Inc. recovery2025 Price Action Summary & Low Risk Entry Point Tips - newser.com
Is it too late to sell TuHURA Biosciences Inc.Trade Risk Summary & Safe Entry Momentum Tips - newser.com
Applying Wyckoff theory to TuHURA Biosciences Inc. stockSwing Trade & Community Consensus Picks - newser.com
What earnings revisions data tells us about TuHURA Biosciences Inc.Weekly Volume Report & Safe Capital Growth Trade Ideas - newser.com
What moving averages say about TuHURA Biosciences Inc.Bull Run & Fast Exit/Entry Strategy Plans - newser.com
Will TuHURA Biosciences Inc. rebound enough to break even2025 Biggest Moves & AI Powered Buy/Sell Recommendations - newser.com
Is TuHURA Biosciences Inc. stock in correction or buying zoneJuly 2025 Sentiment & Expert Verified Movement Alerts - newser.com
Will TuHURA Biosciences Inc. (PL3) stock hit analyst forecastsTrade Exit Report & Low Drawdown Trading Strategies - newser.com
How TuHURA Biosciences Inc. (PL3) stock valuation compares with sectorWeekly Market Outlook & Low Volatility Stock Recommendations - newser.com
TuHURA Biosciences Inc. stock volume spike explainedWeekly Gains Summary & Technical Entry and Exit Tips - newser.com
How TuHURA Biosciences Inc. stock benefits from strong dollarRecession Risk & AI Based Buy and Sell Signals - newser.com
Is TuHURA Biosciences Inc. stock gaining market shareJuly 2025 EndofMonth & Precise Swing Trade Entry Alerts - newser.com
Can TuHURA Biosciences Inc. (PL3) stock retain market dominance2025 Volume Leaders & Verified Entry Point Signals - newser.com
Will TuHURA Biosciences Inc. bounce back from current supportOil Prices & Weekly Top Gainers Trade List - newser.com
Multi asset correlation models including TuHURA Biosciences Inc.Rate Cut & Low Risk Growth Stock Ideas - newser.com
Is TuHURA Biosciences Inc. stock a safe investment in uncertain marketsMarket Performance Recap & Daily Technical Stock Forecast Reports - newser.com
TuHURA Biosciences Secures $3M Bridge Loan Agreement - MSN
Why analysts raise outlook for TuHURA Biosciences Inc. (PL3) stock - newser.com
Using Ichimoku Cloud for TuHURA Biosciences Inc. technicals2025 Year in Review & Short-Term Trading Opportunity Alerts - newser.com
Can technical indicators confirm TuHURA Biosciences Inc.’s reversal2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com
Will TuHURA Biosciences Inc. (PL3) stock deliver compounding returnsJuly 2025 Setups & Fast Entry Momentum Trade Alerts - newser.com
Finanzdaten der Tuhura Biosciences Inc-Aktie (HURA)
        Es liegen keine Finanzdaten für Tuhura Biosciences Inc (HURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
    
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):